139 related articles for article (PubMed ID: 11592062)
1. Vascular adhesion protein-1 (VAP-1) mediates lymphocyte-endothelial interactions in chronic kidney rejection.
Kurkijärvi R; Jalkanen S; Isoniemi H; Salmi M
Eur J Immunol; 2001 Oct; 31(10):2876-84. PubMed ID: 11592062
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1).
Arvilommi AM; Salmi M; Kalimo K; Jalkanen S
Eur J Immunol; 1996 Apr; 26(4):825-33. PubMed ID: 8625974
[TBL] [Abstract][Full Text] [Related]
3. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.
Lalor PF; Edwards S; McNab G; Salmi M; Jalkanen S; Adams DH
J Immunol; 2002 Jul; 169(2):983-92. PubMed ID: 12097405
[TBL] [Abstract][Full Text] [Related]
4. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear.
Salmi M; Tohka S; Jalkanen S
Circ Res; 2000 Jun; 86(12):1245-51. PubMed ID: 10864915
[TBL] [Abstract][Full Text] [Related]
5. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
6. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma.
Yoong KF; McNab G; Hübscher SG; Adams DH
J Immunol; 1998 Apr; 160(8):3978-88. PubMed ID: 9558106
[TBL] [Abstract][Full Text] [Related]
7. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells.
Salmi M; Jalkanen S
J Exp Med; 1996 Feb; 183(2):569-79. PubMed ID: 8627168
[TBL] [Abstract][Full Text] [Related]
8. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes.
Salmi M; Tohka S; Berg EL; Butcher EC; Jalkanen S
J Exp Med; 1997 Aug; 186(4):589-600. PubMed ID: 9254657
[TBL] [Abstract][Full Text] [Related]
9. The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes.
Salmi M; Hellman J; Jalkanen S
J Immunol; 1998 Jun; 160(11):5629-36. PubMed ID: 9605169
[TBL] [Abstract][Full Text] [Related]
10. Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium.
Irjala H; Salmi M; Alanen K; Grénman R; Jalkanen S
J Immunol; 2001 Jun; 166(11):6937-43. PubMed ID: 11359855
[TBL] [Abstract][Full Text] [Related]
11. Induction and function of vascular adhesion protein-1 at sites of inflammation.
Salmi M; Kalimo K; Jalkanen S
J Exp Med; 1993 Dec; 178(6):2255-60. PubMed ID: 8245796
[TBL] [Abstract][Full Text] [Related]
12. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule.
Smith DJ; Salmi M; Bono P; Hellman J; Leu T; Jalkanen S
J Exp Med; 1998 Jul; 188(1):17-27. PubMed ID: 9653080
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1).
Koskinen K; Vainio PJ; Smith DJ; Pihlavisto M; Ylä-Herttuala S; Jalkanen S; Salmi M
Blood; 2004 May; 103(9):3388-95. PubMed ID: 14726375
[TBL] [Abstract][Full Text] [Related]
14. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models.
Salmi M; Jalkanen S
Eur J Immunol; 1995 Oct; 25(10):2803-12. PubMed ID: 7589075
[TBL] [Abstract][Full Text] [Related]
15. Sialyl Lewis(x)- and L-selectin-dependent site-specific lymphocyte extravasation into renal transplants during acute rejection.
Turunen JP; Paavonen T; Majuri ML; Tiisala S; Mattila P; Mennander A; Gahmberg CG; Häyry P; Tamatani T; Miyasaka M
Eur J Immunol; 1994 May; 24(5):1130-6. PubMed ID: 7514129
[TBL] [Abstract][Full Text] [Related]
16. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion.
Lalor PF; Sun PJ; Weston CJ; Martin-Santos A; Wakelam MJ; Adams DH
Hepatology; 2007 Feb; 45(2):465-74. PubMed ID: 17256751
[TBL] [Abstract][Full Text] [Related]
17. Human vascular adhesion protein-1 in smooth muscle cells.
Jaakkola K; Kaunismäki K; Tohka S; Yegutkin G; Vänttinen E; Havia T; Pelliniemi LJ; Virolainen M; Jalkanen S; Salmi M
Am J Pathol; 1999 Dec; 155(6):1953-65. PubMed ID: 10595925
[TBL] [Abstract][Full Text] [Related]
18. Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats.
Martelius T; Salmi M; Wu H; Bruggeman C; Höckerstedt K; Jalkanen S; Lautenschlager I
Am J Pathol; 2000 Oct; 157(4):1229-37. PubMed ID: 11021827
[TBL] [Abstract][Full Text] [Related]
19. Blockade of vascular adhesion protein-1 inhibits lymphocyte infiltration in rat liver allograft rejection.
Martelius T; Salaspuro V; Salmi M; Krogerus L; Höckerstedt K; Jalkanen S; Lautenschlager I
Am J Pathol; 2004 Dec; 165(6):1993-2001. PubMed ID: 15579442
[TBL] [Abstract][Full Text] [Related]
20. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding.
Jalkanen S; Karikoski M; Mercier N; Koskinen K; Henttinen T; Elima K; Salmivirta K; Salmi M
Blood; 2007 Sep; 110(6):1864-70. PubMed ID: 17548577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
